Porton Pharma Solutions Ltd. (300363.SZ) — Stock Score Summary

Porton Pharma Solutions Ltd. (300363.SZ) has a MoatMap StockRank of 30/100 based on Quality (49/100), Value (37/100), and Momentum (31/100) factor scores. The current signal is SELL. Porton Pharma Solutions is a leading Chinese CDMO. While it stands to benefit from the global CDMO Pricing Power Cycle, severe geopolitical overhangs (such as the US Biosecure Act) create a significant risk of Western pharma clients diversifying away from Chinese manufacturers.

Porton Pharma Solutions Ltd. is a leading global pharmaceutical Contract Development and Manufacturing Organization (CDMO) providing end-to-end services for small molecules, biologics, and CGT. The company serves top-tier multinational pharmaceutical firms, leveraging its advanced chemical synthesis capabilities and GMP-compliant facilities. Its deep integration into global drug supply chains and stringent IP protection standards form a highly resilient competitive moat.

Key Financial Metrics

Price$2.06
Market Cap$1.2B
P/E (TTM)57.88
P/E (Forward)23.95
Price/Book1.44
Return on Equity1.1%
Return on Invested Capital2.0%
Debt/Equity27.14
Gross Margin30.1%
Operating Margin5.0%
Revenue Growth10.6%
Dividend Yield0.6%
Free Cash Flow$6M

Porton Pharma Solutions Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Porton Pharma Solutions Ltd.’s (300363.SZ) StockRank?
MoatMap’s StockRank for Porton Pharma Solutions Ltd. (300363.SZ) is 30/100, with a Sell signal. It is a composite of Quality (49), Value (37), and Momentum (31) factor ranks across MoatMap’s 19,000+ stock universe.
Does Porton Pharma Solutions Ltd. have an economic moat?
Porton Pharma Solutions Ltd. (300363.SZ) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Porton Pharma Solutions Ltd. a buy, hold, or sell?
MoatMap’s current signal for Porton Pharma Solutions Ltd. (300363.SZ) is Sell, based on a StockRank of 30/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Porton Pharma Solutions Ltd. in?
Porton Pharma Solutions Ltd. (300363.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks300363.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock